Calamine lotion to reduce skin irritation in children with cast immobilisation

May Fong Mak1, Wenyun Li, Arjandas Mahadev

  • 1Department of Orthopaedic Surgery, Kandang Kerbau Women's and Children's Hospital, Singapore.

Insights

Calamine lotion significantly reduced skin irritation, itch, and sweat in children with limb fracture casts. It also decreased the likelihood of developing skin lesions during immobilization.

Area of Science:

  • Pediatric Orthopedics
  • Dermatology
  • Clinical Trials

Background:

  • Skin irritation is a common complication in children with cast immobilization.
  • Factors contributing to skin irritation include itch, sweat, and heat.
  • Identifying effective interventions is crucial for improving patient comfort and outcomes.

Purpose of the Study:

  • To assess the efficacy of calamine lotion in mitigating skin irritation in pediatric patients undergoing cast immobilization.
  • To identify specific factors associated with the development of skin irritation in this population.

Main Methods:

  • A randomized controlled trial involving 250 children (aged 6-15 years) with limb fractures treated with casts.
  • Participants were allocated to either a calamine lotion group or a non-calamine control group.
  • Data on itch, sweat, heat, and skin lesions were collected, with adjustments for potential confounders.

Main Results:

  • The calamine group exhibited significantly lower rates of skin lesions (OR=0.063, p=0.003) and reduced itch levels (p<0.0001).
  • Children using calamine lotion also reported lower sweat levels (p=0.048).
  • Older age and shorter casting duration were correlated with increased skin lesion occurrence.

Conclusions:

  • Calamine lotion demonstrates a beneficial effect in reducing skin irritation in children with full casts.
  • The findings suggest calamine lotion as a potential adjunctive treatment for managing cast-related skin issues.
  • Further research could explore long-term effects and optimal application protocols.

Related Concept Videos

Decreased Body Temperature01:29

Decreased Body Temperature

A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by sustained extreme cold exposure, and severe...
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Classification of Skeletal Muscle Relaxants01:28

Classification of Skeletal Muscle Relaxants

Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Spasmolytic Agents: Chemical Classification01:29

Spasmolytic Agents: Chemical Classification

Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also promote...